Table of Contents Author Guidelines Submit a Manuscript
Journal of Immunology Research
Volume 2016, Article ID 6765134, 11 pages
http://dx.doi.org/10.1155/2016/6765134
Research Article

Systemic Administration of Proteoglycan Protects BALB/c Retired Breeder Mice from Experimental Arthritis

1Department of Microbiology and Immunology, Institute of Biosciences of Botucatu, São Paulo State University (UNESP), 18618-689 Botucatu, SP, Brazil
2Department of Pathology, Botucatu Medical School, 18618-970 Botucatu, SP, Brazil
3Laboratory of Flow Cytometry, Amaral Carvalho Foundation, 17210-120 Jaú, SP, Brazil

Received 27 January 2016; Revised 17 April 2016; Accepted 20 April 2016

Academic Editor: Oscar Bottasso

Copyright © 2016 Larissa Lumi Watanabe Ishikawa et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. World Health Organization (WHO) Scientific Group, The Burden of Musculoskeletal Conditions at the Start of the New Millennium, vol. 919 of World Health Organization Technical Report Series, WHO, Geneva, Switzerland, 2003.
  2. L. Klareskog, V. Malmström, K. Lundberg, L. Padyukov, and L. Alfredsson, “Smoking, citrullination and genetic variability in the immunopathogenesis of rheumatoid arthritis,” Seminars in Immunology, vol. 23, no. 2, pp. 92–98, 2011. View at Publisher · View at Google Scholar · View at Scopus
  3. D. L. Scott, F. Wolfe, and T. W. J. Huizinga, “Rheumatoid arthritis,” The Lancet, vol. 376, no. 9746, pp. 1094–1108, 2010. View at Publisher · View at Google Scholar · View at Scopus
  4. D. M. Lee and M. E. Weinblatt, “Rheumatoid arthritis,” The Lancet, vol. 358, no. 9285, pp. 903–911, 2001. View at Publisher · View at Google Scholar · View at Scopus
  5. E. Assier, M.-C. Boissier, and J.-M. Dayer, “Interleukin-6: from identification of the cytokine to development of targeted treatments,” Joint Bone Spine: Revue du Rhumatisme, vol. 77, no. 6, pp. 532–536, 2010. View at Publisher · View at Google Scholar · View at Scopus
  6. J. B. Imboden, “The immunopathogenesis of rheumatoid arthritis,” Annual Review of Pathology: Mechanisms of Disease, vol. 4, pp. 417–434, 2009. View at Publisher · View at Google Scholar · View at Scopus
  7. L. L. W. Ishikawa, Y. Shoenfeld, and A. Sartori, “Immunomodulation in human and experimental arthritis: including vitamin D, helminths and heat-shock proteins,” Lupus, vol. 23, no. 6, pp. 577–587, 2014. View at Publisher · View at Google Scholar · View at Scopus
  8. D. D. Brand, A. H. Kang, and E. F. Rosloniec, “The mouse model of collagen-induced arthritis,” Methods in Molecular Medicine, vol. 102, pp. 295–312, 2004. View at Google Scholar · View at Scopus
  9. T. T. Glant, A. Finnegan, and K. Mikecz, “Proteoglycan-induced arthritis: Immune regulation, cellular mechanisms, and genetics,” Critical Reviews in Immunology, vol. 23, no. 3, pp. 199–250, 2003. View at Publisher · View at Google Scholar · View at Scopus
  10. L. L. W. Ishikawa, P. M. Colavite, L. C. da Rosa et al., “Commercial bovine proteoglycan is highly arthritogenic and can be used as an alternative antigen source for PGIA model,” BioMed Research International, vol. 2014, Article ID 148594, 12 pages, 2014. View at Publisher · View at Google Scholar · View at Scopus
  11. L. C. Harrison and D. A. Hafler, “Antigen-specific therapy for autoimmune disease,” Current Opinion in Immunology, vol. 12, no. 6, pp. 704–711, 2000. View at Publisher · View at Google Scholar · View at Scopus
  12. R. Liblau, R. Tisch, N. Bercovici, and H. O. McDevitt, “Systemic antigen in the treatment of T-cell-mediated autoimmune diseases,” Immunology Today, vol. 18, no. 12, pp. 599–604, 1997. View at Publisher · View at Google Scholar · View at Scopus
  13. J. S. Smolen, D. Aletaha, M. Koeller, M. H. Weisman, and P. Emery, “New therapies for treatment of rheumatoid arthritis,” The Lancet, vol. 370, no. 9602, pp. 1861–1874, 2007. View at Publisher · View at Google Scholar · View at Scopus
  14. G. Cappellano, A. D. Woldetsadik, E. Orilieri et al., “Subcutaneous inverse vaccination with PLGA particles loaded with a MOG peptide and IL-10 decreases the severity of experimental autoimmune encephalomyelitis,” Vaccine, vol. 32, no. 43, pp. 5681–5689, 2014. View at Publisher · View at Google Scholar · View at Scopus
  15. K. Schinnerling, L. Soto, P. García-González, D. Catalán, and J. C. Aguillón, “Skewing dendritic cell differentiation towards a tolerogenic state for recovery of tolerance in rheumatoid arthritis,” Autoimmunity Reviews, vol. 14, no. 6, pp. 517–527, 2015. View at Publisher · View at Google Scholar · View at Scopus
  16. K. Mahnke, T. S. Johnson, S. Ring, and A. H. Enk, “Tolerogenic dendritic cells and regulatory T cells: a two-way relationship,” Journal of Dermatological Science, vol. 46, no. 3, pp. 159–167, 2007. View at Publisher · View at Google Scholar · View at Scopus
  17. A. M. Gizinski and D. A. Fox, “T cell subsets and their role in the pathogenesis of rheumatic disease,” Current Opinion in Rheumatology, vol. 26, no. 2, pp. 204–210, 2014. View at Publisher · View at Google Scholar · View at Scopus
  18. Z. Hunter, D. P. McCarthy, W. T. Yap et al., “A biodegradable nanoparticle platform for the induction of antigen-specific immune tolerance for treatment of autoimmune disease,” ACS Nano, vol. 8, no. 3, pp. 2148–2160, 2014. View at Publisher · View at Google Scholar · View at Scopus
  19. L. C. Harrison, J. M. Wentworth, Y. Zhang et al., “Antigen-based vaccination and prevention of type 1 diabetes,” Current Diabetes Reports, vol. 13, no. 5, pp. 616–623, 2013. View at Publisher · View at Google Scholar · View at Scopus
  20. J. P. S. Peron, K. Yang, M.-L. Chen et al., “Oral tolerance reduces Th17 cells as well as the overall inflammation in the central nervous system of EAE mice,” Journal of Neuroimmunology, vol. 227, no. 1-2, pp. 10–17, 2010. View at Publisher · View at Google Scholar · View at Scopus
  21. K. G. Warren, I. Catz, and K. W. Wucherpfennig, “Tolerance induction to myelin basic protein by intravenous synthetic peptides containing epitope P85 VVHFFKNIVTP96 in chronic progressive multiple sclerosis,” Journal of the Neurological Sciences, vol. 152, no. 1, pp. 31–38, 1997. View at Publisher · View at Google Scholar · View at Scopus
  22. R. Verbeek, K. Van Der Mark, E. F. Wawrousek, A. C. Plomp, and J. M. Van Noort, “Tolerization of an established αb-crystallin-reactive T-cell response by intravenous antigen,” Immunology, vol. 121, no. 3, pp. 416–426, 2007. View at Publisher · View at Google Scholar · View at Scopus
  23. M. L. Gumanovskaya, L. K. Myers, E. F. Rosloniec, J. M. Stuart, and A. H. Kang, “Intravenous tolerization with type II collagen induces interleukin-4- and interleukin-10-producing CD4+ T cells,” Immunology, vol. 97, no. 3, pp. 466–473, 1999. View at Publisher · View at Google Scholar · View at Scopus
  24. L. Chen, B. Bao, N. Wang, J. Xie, and W. Wu, “Oral administration of shark type II collagen suppresses complete Freund's adjuvant-induced rheumatoid arthritis in rats,” Pharmaceuticals, vol. 5, no. 4, pp. 339–352, 2012. View at Publisher · View at Google Scholar · View at Scopus
  25. M. Kunz and S. M. Ibrahim, “Cytokines and cytokine profiles in human autoimmune diseases and animal models of autoimmunity,” Mediators of Inflammation, vol. 2009, Article ID 979258, 20 pages, 2009. View at Publisher · View at Google Scholar · View at Scopus
  26. J. Xu, B. Ehrman, L. M. Graham, and M. J. Eagleton, “Interleukin-5 is a potential mediator of angiotensin II-induced aneurysm formation in apolipoprotein E knockout mice,” The Journal of Surgical Research, vol. 178, no. 1, pp. 512–518, 2012. View at Publisher · View at Google Scholar · View at Scopus
  27. H.-K. Park, M. K. Cho, H. Y. Park et al., “Macrophage migration inhibitory factor isolated from a parasite inhibited Th2 cytokine production in PBMCs of atopic asthma patients,” The Journal of Asthma, vol. 49, no. 1, pp. 10–15, 2012. View at Publisher · View at Google Scholar · View at Scopus
  28. A.-S. Cheng, Y.-H. Cheng, and T.-L. Chang, “Scopoletin attenuates allergy by inhibiting Th2 cytokines production in EL-4 T cells,” Food & Function, vol. 3, no. 8, pp. 886–890, 2012. View at Publisher · View at Google Scholar · View at Scopus
  29. G. den Hartog, H. F. J. Savelkoul, R. Schoemaker et al., “Modulation of human immune responses by bovine interleukin-10,” PLoS ONE, vol. 6, no. 3, Article ID e18188, 2011. View at Publisher · View at Google Scholar · View at Scopus
  30. R. S. Peres, F. Chiuso-Minicucci, L. C. da Rosa et al., “Previous contact with Strongyloides venezuelensis contributed to prevent insulitis in MLD-STZ diabetes,” Experimental Parasitology, vol. 134, no. 2, pp. 183–189, 2013. View at Publisher · View at Google Scholar · View at Scopus
  31. M. Nygårdas, C. Aspelin, H. Paavilainen, M. Röyttä, M. Waris, and V. Hukkanen, “Treatment of experimental autoimmune encephalomyelitis in SJL/J mice with a replicative HSV-1 vector expressing interleukin-5,” Gene Therapy, vol. 18, no. 7, pp. 646–655, 2011. View at Publisher · View at Google Scholar · View at Scopus
  32. G. Tiegs and A. W. Lohse, “Immune tolerance: what is unique about the liver,” Journal of Autoimmunity, vol. 34, no. 1, pp. 1–6, 2010. View at Publisher · View at Google Scholar · View at Scopus
  33. S. R. Satpute, R. Rajaiah, S. K. Polumuri, and K. D. Moudgil, “Tolerization with Hsp65 induces protection against adjuvant-induced arthritis by modulating the antigen-directed interferon-γ, interleukin-17, and antibody responses,” Arthritis & Rheumatism, vol. 60, no. 1, pp. 103–113, 2009. View at Publisher · View at Google Scholar · View at Scopus
  34. R. P. Singh, S. Hasan, S. Sharma et al., “Th17 cells in inflammation and autoimmunity,” Autoimmunity Reviews, vol. 13, no. 12, pp. 1174–1181, 2014. View at Publisher · View at Google Scholar · View at Scopus
  35. D. V. Sawant and D. A. A. Vignali, “Once a Treg, always a Treg?” Immunological Reviews, vol. 259, no. 1, pp. 173–191, 2014. View at Publisher · View at Google Scholar · View at Scopus
  36. M. Noack and P. Miossec, “Th17 and regulatory T cell balance in autoimmune and inflammatory diseases,” Autoimmunity Reviews, vol. 13, no. 6, pp. 668–677, 2014. View at Publisher · View at Google Scholar · View at Scopus
  37. L. Cosmi, V. Santarlasci, L. Maggi, F. Liotta, and F. Annunziato, “Th17 plasticity: pathophysiology and treatment of chronic inflammatory disorders,” Current Opinion in Pharmacology, vol. 17, no. 1, pp. 12–16, 2014. View at Publisher · View at Google Scholar · View at Scopus
  38. T. Wang, X. Sun, J. Zhao et al., “Regulatory T cells in rheumatoid arthritis showed increased plasticity toward Th17 but retained suppressive function in peripheral blood,” Annals of the Rheumatic Diseases, vol. 74, no. 6, pp. 1293–1301, 2015. View at Publisher · View at Google Scholar · View at Scopus
  39. M.-C. Boissier, L. Semerano, S. Challal, N. Saidenberg-Kermanac'h, and G. Falgarone, “Rheumatoid arthritis: from autoimmunity to synovitis and joint destruction,” Journal of Autoimmunity, vol. 39, no. 3, pp. 222–228, 2012. View at Publisher · View at Google Scholar · View at Scopus
  40. H. Radner and D. Aletaha, “Anti-TNF in rheumatoid arthritis: an overview,” Wiener Medizinische Wochenschrift, vol. 165, no. 1-2, pp. 3–9, 2015. View at Publisher · View at Google Scholar · View at Scopus
  41. G. W. Kim, N. R. Lee, R. H. Pi et al., “IL-6 inhibitors for treatment of rheumatoid arthritis: past, present, and future,” Archives of Pharmacal Research, vol. 38, no. 5, pp. 575–584, 2015. View at Publisher · View at Google Scholar · View at Scopus
  42. T. M. Hering, J. Kollar, and T. D. Huynh, “Complete coding sequence of bovine aggrecan: comparative structural analysis,” Archives of Biochemistry and Biophysics, vol. 345, no. 2, pp. 259–270, 1997. View at Publisher · View at Google Scholar · View at Scopus
  43. F. Chiuso-Minicucci, L. L. Ishikawa, L. A. Mimura et al., “Treatment with vitamin D/MOG association suppresses experimental autoimmune encephalomyelitis,” PLoS ONE, vol. 10, no. 5, Article ID e0125836, 2015. View at Publisher · View at Google Scholar · View at Scopus
  44. L. A. Mimura, F. Chiuso-Minicucci, T. F. Fraga-Silva et al., “Association of myelin peptide with vitamin D prevents autoimmune encephalomyelitis development,” Neuroscience, vol. 317, pp. 130–140, 2016. View at Publisher · View at Google Scholar
  45. Y. Yoshida, T. Tsuji, S. Watanabe et al., “Efficacy of combination treatment with fingolimod (FTY720) plus pathogenic autoantigen in a glucose-6-phosphate isomerase peptide (GPI325–339)-induced arthritis mouse model,” Biological & Pharmaceutical Bulletin, vol. 36, no. 11, pp. 1739–1746, 2013. View at Publisher · View at Google Scholar · View at Scopus
  46. J.-E. Park, J. Jang, J.-H. Choi et al., “DC-based immunotherapy combined with low-dose methotrexate effective in the treatment of advanced CIA in mice,” Journal of Immunology Research, vol. 2015, Article ID 834085, 15 pages, 2015. View at Publisher · View at Google Scholar · View at Scopus